ALEMBIC PHARMACEUTICALS, INC.

FDA Regulatory Profile

ALEMBIC PHARMACEUTICALS, INC. appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1086-2023, Class III) was initiated on July 27, 2023.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1086-2023Class IIITobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic PharmaceuticJuly 27, 2023
D-0941-2023Class IIDiclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, ManufactureJune 22, 2023